Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) (FMS)
Stock · NYSE · Health Care
$22.16as of 10/16/2026
Price chart
Active signals
FMS Signal Track Record
How signals performed across all stocks →What FMS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 43 | -0.1% | 49% | September 24, 2026 |
| Bollinger Band Breakdown | 23 | -0.3% | 48% | October 7, 2026 |
| Bollinger Band Breakout | 20 | -1.0% | 45% | July 30, 2026 |
| 200-Day Moving Average TouchActive now | 16 | +4.3% | 75% | September 22, 2026 |
| Any 20-session window (baseline) | +0.3% | 51% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About FMS
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery o…
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- Employees
- 107,226
Fundamentals
- 1-day range
- $21.84$22.28
- Market cap
- $13.46B
- P/E (trailing)
- 10.86
- P/E (forward)
- 7.40
- EPS (trailing)
- $3.33
- Dividend yield
- 3.06%
- Beta
- 0.22
- Avg. volume
- 790.3K
- Ex-dividend date
- May 22, 2026
- Dividend pay date
- June 8, 2026
Forecasts
7 analyst ratings
Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) Competitors
Chosen by industry and closest market cap.
- FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)$22.17▲ 0.18%Market cap $13.46BP/E 10.86$34.57$47.54
- DVADaVita Inc. Common Stock$187.31▼ 0.98%Market cap $11.53BP/E 13.65$101$247.49
- SHCSotera Health Company Common Stock$17.89▼ 1.00%Market cap $5.39BP/E 31.54$13.09$19.85
- PGNYProgyny Inc. Common Stock$26.86▼ 2.17%Market cap $2.37BP/E 25.32$16.1$33.07
- AGLagilon health inc. Common Stock$85.12▼ 3.76%Market cap $1.45BP/E —$7.48$133.04
- VMDViemed Healthcare Inc. Common Shares$9.48▼ 2.77%Market cap $362.60MP/E 25.72$6.05$12.61
- PARKPark Dental Partners Inc. Common Stock$18.95▼ 1.33%Market cap $96.71MP/E —$9.53$26.79
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| FMS Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) | $13.46B | 10.86 | $22.17 | ▲ 0.18% | $34.57$47.54 |
| DVA DaVita Inc. Common Stock | $11.53B | 13.65 | $187.31 | ▼ 0.98% | $101$247.49 |
| SHC Sotera Health Company Common Stock | $5.39B | 31.54 | $17.89 | ▼ 1.00% | $13.09$19.85 |
| PGNY Progyny Inc. Common Stock | $2.37B | 25.32 | $26.86 | ▼ 2.17% | $16.1$33.07 |
| AGL agilon health inc. Common Stock | $1.45B | — | $85.12 | ▼ 3.76% | $7.48$133.04 |
| VMD Viemed Healthcare Inc. Common Shares | $362.60M | 25.72 | $9.48 | ▼ 2.77% | $6.05$12.61 |
| PARK Park Dental Partners Inc. Common Stock | $96.71M | — | $18.95 | ▼ 1.33% | $9.53$26.79 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Truist Securities Maintains Hold on Fresenius Medical Care, Lowers Price Target to $24benzinga · 10/12/2026
- Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growthYahoo · 10/7/2026
- Fresenius Medical Care Appoints Shervin J. Korangy As CEO Effective October 12; Shervin J. Korangy To Succeed Helen GizaBenzinga · 10/7/2026
- Fresenius Medical Care: Margin Expansion Supports The Story, But Growth Remains LimitedSeekingAlpha · 10/7/2026
- European Equities Traded in the US as American Depositary Receipts Lower in Tuesday TradingYahoo · 9/29/2026
- Fresenius Medical Care Reshapes China Portfolio for Long-Term GrowthYahoo · 9/29/2026
- Fresenius Medical Care Refines China Strategy With Targeted Product FocusBenzinga · 9/25/2026
- Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market LeadershipYahoo · 9/25/2026
- Fresenius Medical Care Adjusts China Commercial Strategy To Support Long-Term Growth And Strengthen Market Position Through More Localized Portfolio, Increased Commercialization Of Local Innovation And Focused Go-To-Market PlansBenzinga · 9/25/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 42.13M
- Total value held
- $928.01M
- Institutional holders
- 215
- Unknown15.05M
- Unknown4.46M
- Unknown3.83M
- Unknown2.48M
- Unknown1.64M
- Unknown1.61M
- Unknown1.30M
- Unknown818.0K
- Unknown816.2K
- Unknown775.0K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Fresenius Medical Care Adjusts China Portfolio Amid ADR Decline
European ADRs fell on Tuesday, putting pressure on U.S. listed shares. FMS, part of that group, announced a reshaping of its China portfolio to support long‑term growth. The move signals a focus on core markets while the ADR market remains subdued.
Fresenius Medical Care Adjusts China Portfolio Amid ADR Decline. European ADRs fell on Tuesday, putting pressure on U.S. listed shares. FMS, part of that group, announced a reshaping of its China portfolio to support long‑term growth. The move signals a focus on core markets while the ADR market remains subdued.